封面
市场调查报告书
商品编码
1448070

阿什瓦甘达市场 - 2023-2030

Ashwagandha Market - 2023-2030

出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年,全球南非醉茄市场规模达8.6412亿美元,预计2030年将达到13,566.2亿美元,2023-2030年预测期间CAGR为5.8%。

消费者高度采用南非醉茄及其产品,因为南非醉茄被认为是自古以来的天然阿育吠陀草药。它被广泛用作治疗压力和焦虑的适应原药物,它也有助于治疗各种疾病,如癌症、糖尿病等。因此,这些因素可能有助于推动全球南非醉茄市场的发展。

此外,为了满足对天然补充剂产品不断增长的需求,製造公司正在积极创造和推出创新产品来满足消费者的需求。例如,2023 年 4 月,总部位于南加州的补充剂公司 Youtheory 更新了其产品组合。 Ashwagandha + GABA 含有 100 毫克药物 GABA。它被证明可以克服压力并促进放鬆,而不促进困倦。

以运动和营养为主的南非醉茄补充剂和亚太地区占据了全球南非醉茄市场的最大份额。 Ashwagandha 被认为是自古以来的阿育吠陀药物。政府和製造商也提供了一些扩大市场成长的措施。

动力学

对 Ashwagandha 补充剂的需求不断增加

消费者正在高度寻求合成药物的替代来源,这可以极大地帮助增加对南非醉茄作为天然补充剂的需求,因为它们的适应原特性有助于控制压力和焦虑。因此,对南非醉茄补充剂的需求不断增长正在推动全球南非醉茄市场的成长。

此外,对基于南非醉茄的补充剂的需求增加有助于为製造商创造创新产品的机会。例如,2021年2月,LupinLife公司推出了一款男性阿育吠陀能量补充剂Be One。它是一种 100% 奥吠陀健康和保健补充剂,含有南非醉茄等天然成分。

对阿育吠陀药物的需求不断增加

由于对阿育吠陀药物的需求不断增加,预计南非醉茄萃取物的市场将显着成长。这些萃取物是一种天然药物形式,传统上用于阿育吠陀治疗,以解决各种健康问题,包括但不限于痤疮、焦虑和心血管疾病。

此外,製造公司正在推出南非醉茄的阿育吠陀产品,以扩大其市场规模。例如,2024 年 1 月,Hi-Tech Pharmaceuticals 推出了 Ashwagandha 品牌的 AshwaPure,它是所有主要根中浓度最高的,有助于减轻焦虑、降低血糖水平、力量和耐力。

过敏反应

Ashwagandha 具有许多药用特性,但需要注意的是,有些人可能会对它过敏。过敏反应多种多样,从瘙痒和皮疹等轻微症状到肿胀和呼吸困难等更严重的反应。这可能会限制消费者数量并影响市场的成长。

目录

目录

第 1 章:方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章:定义与概述

第 3 章:执行摘要

  • 按类型分類的片段
  • 按产品类型分類的片段
  • 按表格列出的片段
  • 按功能分類的片段
  • 按配销通路分類的片段
  • 按应用程式片段
  • 按地区分類的片段

第 4 章:动力学

  • 影响因素
    • 司机
      • 对 Ashwagandha 补充剂的需求不断增加
      • 对阿育吠陀药物的需求不断增加
    • 限制
      • 过敏反应
    • 机会
    • 影响分析

第 5 章:产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • DMI 意见

第 6 章:COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章:按类型

  • KSM-66
  • 感应器
  • 水醇阿什瓦甘达
  • 粗南非醉茄

第 8 章:依产品类型

  • 南非醉茄根
  • 阿什瓦甘达叶
  • 根混合产品
  • 醉茄内酯含量(1%-10%)
  • 其他的

第 9 章:按形式

  • 粉末
  • 胶囊
  • 药丸
  • 液体

第 10 章:按功能

  • 提高耐力
  • 提高免疫力
  • 整体健康
  • 减少焦虑和压力
  • 大脑健康
  • 肌肉力量
  • 其他的

第 11 章:按配销通路

  • 大型超市/超市
  • 专卖店
  • 药局和药房
  • 便利商店
  • 网路零售通路
  • 其他的

第 12 章:按应用

  • 食品和饮料
  • 製药
  • 运动营养
  • 其他的

第 13 章:按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第14章:竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 15 章:公司简介

  • Baldwa group
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Sami-Sabinsa Group
  • Dabur India Ltd
  • Himalaya Wellness Company.
  • Swanson
  • Patanjali Ayurved Limited
  • Kerry Group plc
  • KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED
  • Bioprex Labs
  • Medikonda Nutrients.

第 16 章:附录

简介目录
Product Code: FB8146

Overview

Global Ashwagandha Market reached US$ 864.12 million in 2022 and is expected to reach US$ 1356.62 billion by 2030, growing with a CAGR of 5.8% during the forecast period 2023-2030.

Consumers are highly adopting the ashwagandha and their products, as the ashwagandha is considered a natural ayurvedic herb from ancient times. It is highly used as adaptogen medicine for stress and anxiety, it also helps to cure various diseases such as cancer, diabetes, and others. Hence, such factors can contribute to driving the global ashwagandha market.

Furthermore, in response to the growing demand for natural supplement products, manufacturing companies are actively creating and introducing innovative products to meet consumer needs. For instance, in April 2023, Southern California-based supplement company- Youtheory updated its portfolios. Ashwagandha + GABA has 100mg of pharma GABA. It is shown to overcome stress and encourage relaxation, without promoting sleepiness.

The sports and nutrition-based ashwagandha supplements and Asia-Pacific region accounted for the largest share of the global ashwagandha market. Ashwagandha is believed to be the Ayurvedic medicine from ancient times. The government and manufacturers also provide some initiatives to expand the market growth.

Dynamics

Increasing Demand for Ashwagandha Supplements

Consumers are highly seeking alternative sources of synthetic drugs, which can significantly help in increasing the demand for ashwagandha as a natural supplement, as their adaptogenic properties help in managing stress and anxiety. Hence, the increasing demand for ashwagandha supplements is propelling the growth of the global ashwagandha market.

Furthermore, the increased demand for ashwagandha-based supplements can help to create opportunities for manufacturers to create innovative products. For instance, in February 2021, LupinLife company launched an ayurvedic energy supplement for men, Be One. It is a 100% aurvedic health and wellness supplement, which contains natural ingredients including ashwagandha.

Increasing Demand for Ayurvedic Medicines

The market for ashwagandha extracts is predicted to grow significantly due to the increasing demand for ayurvedic medicines. These extracts are a natural form of medicine that have been traditionally used in ayurvedic treatments to address various health conditions, including but not limited to acne, anxiety, and cardiovascular diseases.

In addition, the manufacturing companies are launching ayurvedic products of ashwagandha to expand their market sizes. For instance, in January 2024, Hi-Tech Pharmaceuticals launched AshwaPure under the ashwagandha brand, it has the highest concentration of all major roots, and it helps in reducing anxiety, and lowering blood sugar levels, strength, and stamina.

Allergic Reactions

Ashwagandha has many medicinal properties, but it's important to note that some people may be allergic to it. Allergic reactions can vary from mild symptoms like itching and rash to more severe reactions such as swelling and difficulty breathing. This can potentially limit the number of consumers and impact the growth of the market.

Segment Analysis

The global ashwagandha market is segmented based on type, product type, form, function, distribution channel, application, and region.

Increasing Demand for Natural Sport Nutrition Products

The sports nutrition category holds the largest portion of the global ashwagandha market. The sports supplement industry is increasingly incorporating ashwagandha into various products due to its potential to regulate cortisol levels. This herb can help to assist in managing the stress response associated with intense exercise. Additionally, ashwagandha is gaining attention for its potential contributions to strength and muscle mass improvements, along with a positive impact on cardiovascular health.

Furthermore, as the demand for natural sports supplements is increasing among consumers, manufacturing companies are launching innovative products in their portfolios. For instance, in September 2020, India's sports nutrition brand MuscleBlaze combined the merits of immune and sports nutrition into one product, it launched an ashwagandha-enriched whey protein powder Biozyme Immunity Whey.

Geographical Penetration

Government Initiatives and Product Launches

The Asia-Pacific region shows the dominance in global ashwagandha market, as ashwagandha has been widely used as a medicinal and ayurvedic plant from ancient times in India, consumers in this region are highly adopting these ashwagandha and their based products as it offers various potential health benefits. Hence such cultural inclination toward herbal supplements can help in driving the ashwagandha market.

Furthermore, the regional government is developing new initiatives to meet increasing demand. For instance, in October 2022, the government of India launched the cultivation of the medicinal plant Ashwagandha on a 200-acre plantation in the Dindigul district, India. This project aims to make Dindigul a hub for medicinal plants.

Additionally, the manufacturers of this region are actively supporting the growing demand by developing innovative products. For instance, in December 2021, Wellness Brand Nidra Nutrition, a part of Supercluster Pi launched a product line of stress relief gummies containing 175 mg of Ashwagandha in India.

Competitive Landscape

The major global players in the market include Baldwa Group, Sami-Sabinsa Group, Dabur India Ltd, Himalaya Wellness Company., Swanson, Patanjali Ayurved Limited, Kerry Group plc, KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED, Bioprex Labs, and Medikonda Nutrients.

COVID-19 Impact Analysis

The pandemic had brought a significantly positive impact on the global ashwagandha market. Due COVID-19 virus, the pandemic, and the lockdown situation and restrictions have caused stress and anxiety among consumers the coronavirus also affected the immune system of the patients. Ashwagandha helps in enhancing the immune system, this has increased the demand for the ashwagandha market.

Additionally, during COVID-19 consumers widely started adopting natural and ayurvedic products which has raised the demand for the usage of ashwagandha for various herbal and medicinal products to treat anxiety and other issues, this has raised the sales of ashwagandha and ashwagandha-based products.

By Type

  • KSM-66
  • Sensoril
  • Hydro-Alcoholic Ashwagandha
  • Crude Ashwagandha

By Product Type

  • Ashwagandha Root
  • Ashwagandha Leaf
  • Root Mix Products
  • Withanolides Content (1% -10%)
  • Others

By Form

  • Powder
  • Capsule
  • Pills
  • Liquid

By Function

  • Improve Stamina
  • Improve Immunity
  • Overall Wellbeing
  • Reduces Anxiety and Stress
  • Brain Health
  • Muscle Strength
  • Others

By Distribution Channel

  • Hypermarket/Supermarket
  • Specialty Stores
  • Drug Stores & Pharmacies
  • Convenience Stores
  • Online Retail Channels
  • Others

By Application

  • Food & Beverages
  • Sports & Nutrition
  • Pharmaceutical
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In April 2022, Kerry Group PLC, the taste and nutrition company, announced it had completed the acquisition of U.S.-based Natreon, Inc., a leading supplier of branded Ayurvedic botanical ingredients. The acquisition significantly expands Kerry's leadership position and ProActive Health's portfolio of science-backed branded ingredients which includes ashwagandha, and others furthering the company's technology growth.
  • In December 2021, Glanbia Nutritionals PLC partnered with Ixoreal Biomed Inc. to optimize its KSM-66 Ashwagandha, highly concentrated root extract with NutraShield Technology, to provide functional and application dosage improvements.
  • In September 2022, Nutriventia launched sustained-release Prolanza ashwagandha, the pharmacokinetic study concluded that Prolanza had a higher rate of bioavailability and absorption, and a longer shelf-life than another well-known ingredient.

Why Purchase the Report?

  • To visualize the global ashwagandha market segmentation based on type, product type, form, function, distribution channel, application, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of ashwagandha market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global ashwagandha market report would provide approximately 86 tables, 94 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Type
  • 3.2.Snippet by Product Type
  • 3.3.Snippet by Form
  • 3.4.Snippet by Function
  • 3.5.Snippet by Distribution Channel
  • 3.6.Snippet by Application
  • 3.7.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increasing Demand for Ashwagandha Supplements
      • 4.1.1.2.Increasing Demand for Ayurvedic Medicines
    • 4.1.2.Restraints
      • 4.1.2.1.Allergic Reactions
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Type

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 7.1.2.Market Attractiveness Index, By Type
  • 7.2.KSM-66*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Sensoril
  • 7.4.Hydro-Alcoholic Ashwagandha
  • 7.5.Crude Ashwagandha

8.By Product Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2.Market Attractiveness Index, By Product Type
  • 8.2.Ashwagandha Root*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3.Ashwagandha Leaf
  • 8.4.Root Mix Products
  • 8.5.Withanolides Content (1% -10%)
  • 8.6.Others

9.By Form

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.1.2.Market Attractiveness Index, By Form
  • 9.2.Powder*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Capsule
  • 9.4.Pills
  • 9.5.Liquid

10.By Function

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 10.1.2.Market Attractiveness Index, By Function
  • 10.2.Improve Stamina*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Improve Immunity
  • 10.4.Overall Wellbeing
  • 10.5.Reduces Anxiety and Stress
  • 10.6.Brain Health
  • 10.7.Muscle Strength
  • 10.8.Others

11.By Distribution Channel

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.1.2.Market Attractiveness Index, By Distribution Channel
  • 11.2.Hypermarket/Supermarket*
    • 11.2.1.Introduction
    • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3.Specialty Stores
  • 11.4.Drug Stores & Pharmacies
  • 11.5.Convenience Stores
  • 11.6.Online Retail Channels
  • 11.7.Others

12.By Application

  • 12.1.Introduction
    • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.1.2.Market Attractiveness Index, By Application
  • 12.2.Food & Beverages*
    • 12.2.1.Introduction
    • 12.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 12.3.Pharmaceutical
  • 12.4.Sports Nutrition
  • 12.5.Others

13.By Region

  • 13.1.Introduction
    • 13.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 13.1.2.Market Attractiveness Index, By Region
  • 13.2.North America
    • 13.2.1.Introduction
    • 13.2.2.Key Region-Specific Dynamics
    • 13.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.2.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.2.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.2.9.1.U.S.
      • 13.2.9.2.Canada
      • 13.2.9.3.Mexico
  • 13.3.Europe
    • 13.3.1.Introduction
    • 13.3.2.Key Region-Specific Dynamics
    • 13.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.3.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.3.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.3.9.1.Germany
      • 13.3.9.2.UK
      • 13.3.9.3.France
      • 13.3.9.4.Italy
      • 13.3.9.5.Russia
      • 13.3.9.6.Rest of Europe
  • 13.4.South America
    • 13.4.1.Introduction
    • 13.4.2.Key Region-Specific Dynamics
    • 13.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.4.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.4.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.4.9.1.Brazil
      • 13.4.9.2.Argentina
      • 13.4.9.3.Rest of South America
  • 13.5.Asia-Pacific
    • 13.5.1.Introduction
    • 13.5.2.Key Region-Specific Dynamics
    • 13.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 13.5.9.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 13.5.9.1.China
      • 13.5.9.2.India
      • 13.5.9.3.Japan
      • 13.5.9.4.Australia
      • 13.5.9.5.Rest of Asia-Pacific
  • 13.6.Middle East and Africa
    • 13.6.1.Introduction
    • 13.6.2.Key Region-Specific Dynamics
    • 13.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 13.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 13.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 13.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Function
    • 13.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 13.6.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

14.Competitive Landscape

  • 14.1.Competitive Scenario
  • 14.2.Market Positioning/Share Analysis
  • 14.3.Mergers and Acquisitions Analysis

15.Company Profiles

  • 15.1.Baldwa group*
    • 15.1.1.Company Overview
    • 15.1.2.Product Portfolio and Description
    • 15.1.3.Financial Overview
    • 15.1.4.Key Developments
  • 15.2.Sami-Sabinsa Group
  • 15.3.Dabur India Ltd
  • 15.4.Himalaya Wellness Company.
  • 15.5.Swanson
  • 15.6.Patanjali Ayurved Limited
  • 15.7.Kerry Group plc
  • 15.8.KAIRALI AYURVEDIC PRODUCTS PRIVATE LIMITED
  • 15.9.Bioprex Labs
  • 15.10.Medikonda Nutrients.

LIST NOT EXHAUSTIVE

16.Appendix

  • 16.1.About Us and Services
  • 16.2.Contact Us